{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T23:02:53Z","timestamp":1773097373297,"version":"3.50.1"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2023,9,4]],"date-time":"2023-09-04T00:00:00Z","timestamp":1693785600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,9,4]],"date-time":"2023-09-04T00:00:00Z","timestamp":1693785600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Parasitol Res"],"published-print":{"date-parts":[[2023,11]]},"DOI":"10.1007\/s00436-023-07953-w","type":"journal-article","created":{"date-parts":[[2023,9,4]],"date-time":"2023-09-04T04:01:35Z","timestamp":1693800095000},"page":"2539-2548","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["The anti-amoebic potential of carboxamide derivatives containing sulfonyl or sulfamoyl moieties against brain-eating Naegleria fowleri"],"prefix":"10.1007","volume":"122","author":[{"given":"Noor","family":"Akbar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ruqaiyyah","family":"Siddiqui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammed I.","family":"El-Gamal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seyed-Omar","family":"Zaraei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bader S.","family":"Alawfi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naveed Ahmed","family":"Khan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,9,4]]},"reference":[{"key":"7953_CR1","doi-asserted-by":"publisher","first-page":"988","DOI":"10.1017\/S0031182017002189","volume":"145","author":"L Adalid-Peralta","year":"2018","unstructured":"Adalid-Peralta L, S\u00e1enz B, Fragoso G, C\u00e1rdenas G (2018) Understanding host\u2013parasite relationship: the immune central nervous system microenvironment and its effect on brain infections. Parasitol 145:988\u2013999. https:\/\/doi.org\/10.1017\/S0031182017002189","journal-title":"Parasitol"},{"key":"7953_CR2","doi-asserted-by":"publisher","first-page":"lxac030","DOI":"10.1093\/jambio\/lxac030","volume":"134","author":"N Akbar","year":"2023","unstructured":"Akbar N, El-Gamal MI, Zaraei S-O et al (2023) Anti-amoebic activity of a series of benzofuran\/benzothiophene derivatives against Acanthamoeba castellanii belonging to the T4 genotype. J Appl Microbiol 134:lxac030. https:\/\/doi.org\/10.1093\/jambio\/lxac030","journal-title":"J Appl Microbiol"},{"key":"7953_CR3","doi-asserted-by":"publisher","first-page":"964","DOI":"10.3390\/antibiotics10080964","volume":"10","author":"N Akbar","year":"2021","unstructured":"Akbar N, Gul J, Siddiqui R et al (2021) Moxifloxacin and sulfamethoxazole-based nanocarriers exhibit potent antibacterial activities. Antibiotics 10:964. https:\/\/doi.org\/10.3390\/antibiotics10080964","journal-title":"Antibiotics"},{"key":"7953_CR4","doi-asserted-by":"publisher","first-page":"28797","DOI":"10.1021\/acsomega.2c01614","volume":"7","author":"N Akbar","year":"2022","unstructured":"Akbar N, Kaman WE, Sarink M et al (2022) Novel antiamoebic tyrocidine-derived peptide against brain-eating amoebae. ACS Omega 7:28797\u201328805. https:\/\/doi.org\/10.1021\/acsomega.2c01614","journal-title":"ACS Omega"},{"key":"7953_CR5","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1080\/13543776.2021.1910237","volume":"31","author":"HS Anbar","year":"2021","unstructured":"Anbar HS, Isa Z, Elounais JJ et al (2021) Steroid sulfatase inhibitors: the current landscape. Expert Opin Ther Pat 31:453\u2013472. https:\/\/doi.org\/10.1080\/13543776.2021.1910237","journal-title":"Expert Opin Ther Pat"},{"key":"7953_CR6","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1007\/978-1-4471-5226-2_22","volume-title":"Textbook of neurointensive care","author":"LK Archibald","year":"2013","unstructured":"Archibald LK, Quisling RG (2013) Central nervous system infections. In: Layon AJ, Gabrielli A, Friedman WA (eds) Textbook of neurointensive care. Springer, London, London, pp 427\u2013517"},{"key":"7953_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.exppara.2018.02.010","volume":"187","author":"NK Bellini","year":"2018","unstructured":"Bellini NK, Santos TM, da Silva MTA, Thiemann OH (2018) The therapeutic strategies against Naegleria fowleri. Exp Parasitol 187:1\u201311. https:\/\/doi.org\/10.1016\/j.exppara.2018.02.010","journal-title":"Exp Parasitol"},{"key":"7953_CR8","doi-asserted-by":"publisher","first-page":"940","DOI":"10.1099\/mic.0.000500","volume":"163","author":"R C\u00e1rdenas-Z\u00fa\u00f1iga","year":"2017","unstructured":"C\u00e1rdenas-Z\u00fa\u00f1iga R, Silva-Olivares A, Villalba-Magdaleno JDA et al (2017) Amphotericin B induces apoptosis-like programmed cell death in Naegleria fowleri and Naegleria gruberi. Microbiol 163:940\u2013949. https:\/\/doi.org\/10.1099\/mic.0.000500","journal-title":"Microbiol"},{"key":"7953_CR9","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1093\/cid\/civ1021","volume":"62","author":"JR Cope","year":"2016","unstructured":"Cope JR, Conrad DA, Cohen N et al (2016) Use of the novel therapeutic agent miltefosine for the treatment of primary amebic meningoencephalitis: report of 1 fatal and 1 surviving case: Table 1. Clin Infect Dis 62:774\u2013776. https:\/\/doi.org\/10.1093\/cid\/civ1021","journal-title":"Clin Infect Dis"},{"key":"7953_CR10","doi-asserted-by":"publisher","first-page":"e36","DOI":"10.1093\/cid\/civ017","volume":"60","author":"JR Cope","year":"2015","unstructured":"Cope JR, Ratard RC, Hill VR et al (2015) The first association of a primary amebic meningoencephalitis death with culturable Naegleria fowleri in tap water from a US treated public drinking water system. Clin Infect Dis 60:e36\u2013e42. https:\/\/doi.org\/10.1093\/cid\/civ017","journal-title":"Clin Infect Dis"},{"key":"7953_CR11","doi-asserted-by":"publisher","first-page":"e0006104","DOI":"10.1371\/journal.pntd.0006104","volume":"11","author":"A Debnath","year":"2017","unstructured":"Debnath A, Calvet CM, Jennings G et al (2017) CYP51 is an essential drug target for the treatment of primary amoebic meningoencephalitis (PAM). PLoS Negl Trop Dis 11:e0006104. https:\/\/doi.org\/10.1371\/journal.pntd.0006104","journal-title":"PLoS Negl Trop Dis"},{"key":"7953_CR12","doi-asserted-by":"publisher","first-page":"414","DOI":"10.3389\/fmicb.2018.00414","volume":"9","author":"A Debnath","year":"2018","unstructured":"Debnath A, Nelson AT, Silva-Olivares A et al (2018) In vitro efficacy of Ebselen and BAY 11-7082 against Naegleria fowleri. Front Microbiol 9:414. https:\/\/doi.org\/10.3389\/fmicb.2018.00414","journal-title":"Front Microbiol"},{"key":"7953_CR13","doi-asserted-by":"publisher","first-page":"5450","DOI":"10.1128\/AAC.00643-12","volume":"56","author":"A Debnath","year":"2012","unstructured":"Debnath A, Tunac JB, Galindo-G\u00f3mez S et al (2012) Corifungin, a new drug lead against Naegleria, identified from a high-throughput screen. Antimicrob Agents Chemother 56:5450\u20135457. https:\/\/doi.org\/10.1128\/AAC.00643-12","journal-title":"Antimicrob Agents Chemother"},{"key":"7953_CR14","doi-asserted-by":"publisher","first-page":"103677","DOI":"10.1016\/j.bioorg.2020.103677","volume":"97","author":"MI El-Gamal","year":"2020","unstructured":"El-Gamal MI, Omar HA, Semreen MH et al (2020) Antiproliferative activity of cycloalkanecarboxamide derivatives possessing sulfonate or sulfamate moiety. Bioorganic Chem 97:103677. https:\/\/doi.org\/10.1016\/j.bioorg.2020.103677","journal-title":"Bioorganic Chem"},{"key":"7953_CR15","doi-asserted-by":"publisher","first-page":"2762","DOI":"10.1016\/j.bmc.2016.04.040","volume":"24","author":"MI El-Gamal","year":"2016","unstructured":"El-Gamal MI, Semreen MH, Foster PA, Potter BVL (2016) Design, synthesis, and biological evaluation of new arylamide derivatives possessing sulfonate or sulfamate moieties as steroid sulfatase enzyme inhibitors. Bioorg Med Chem 24:2762\u20132767. https:\/\/doi.org\/10.1016\/j.bmc.2016.04.040","journal-title":"Bioorg Med Chem"},{"key":"7953_CR16","doi-asserted-by":"publisher","first-page":"2464","DOI":"10.1021\/acschemneuro.0c00165","volume":"11","author":"JI Escrig","year":"2020","unstructured":"Escrig JI, Hahn HJ, Debnath A (2020) Activity of auranofin against multiple genotypes of Naegleria fowleri and its synergistic effect with amphotericin B in vitro. ACS Chem Neurosci 11:2464\u20132471. https:\/\/doi.org\/10.1021\/acschemneuro.0c00165","journal-title":"ACS Chem Neurosci"},{"key":"7953_CR17","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1016\/j.pop.2018.05.007","volume":"45","author":"RA Giovane","year":"2018","unstructured":"Giovane RA, Lavender PD (2018) Central nervous system infections. Prim Care Clin Off Pract 45:505\u2013518. https:\/\/doi.org\/10.1016\/j.pop.2018.05.007","journal-title":"Prim Care Clin Off Pract"},{"key":"7953_CR18","doi-asserted-by":"publisher","first-page":"6677","DOI":"10.1128\/AAC.01293-15","volume":"59","author":"E Grace","year":"2015","unstructured":"Grace E, Asbill S, Virga K (2015) Naegleria fowleri: pathogenesis, diagnosis, and treatment options. Antimicrob Agents Chemother 59:6677\u20136681. https:\/\/doi.org\/10.1128\/AAC.01293-15","journal-title":"Antimicrob Agents Chemother"},{"key":"7953_CR19","doi-asserted-by":"publisher","first-page":"1320","DOI":"10.3390\/biom11091320","volume":"11","author":"A G\u00fc\u00e9mez","year":"2021","unstructured":"G\u00fc\u00e9mez A, Garc\u00eda E (2021) Primary amoebic meningoencephalitis by Naegleria fowleri: pathogenesis and treatments. Biomolecules 11:1320. https:\/\/doi.org\/10.3390\/biom11091320","journal-title":"Biomolecules"},{"key":"7953_CR20","doi-asserted-by":"publisher","first-page":"3089","DOI":"10.1021\/acschemneuro.0c00428","volume":"11","author":"HJ Hahn","year":"2020","unstructured":"Hahn HJ, Abagyan R, Podust LM et al (2020) HMG-CoA reductase inhibitors as drug leads against Naegleria fowleri. ACS Chem Neurosci 11:3089\u20133096. https:\/\/doi.org\/10.1021\/acschemneuro.0c00428","journal-title":"ACS Chem Neurosci"},{"key":"7953_CR21","doi-asserted-by":"publisher","first-page":"205031211878196","DOI":"10.1177\/2050312118781962","volume":"6","author":"S Jeyamogan","year":"2018","unstructured":"Jeyamogan S, Khan NA, Anwar A et al (2018) Cytotoxic effects of benzodioxane, naphthalene diimide, porphyrin and acetamol derivatives on HeLa cells. SAGE Open Med 6:205031211878196. https:\/\/doi.org\/10.1177\/2050312118781962","journal-title":"SAGE Open Med"},{"key":"7953_CR22","doi-asserted-by":"publisher","first-page":"e00637","DOI":"10.1128\/mSphere.00637-21","volume":"6","author":"SJ Joseph","year":"2021","unstructured":"Joseph SJ, Park S, Kelley A et al (2021) Comparative genomic and transcriptomic analysis of Naegleria fowleri clinical and environmental isolates. mSphere 6:e00637. https:\/\/doi.org\/10.1128\/mSphere.00637-21","journal-title":"mSphere"},{"key":"7953_CR23","doi-asserted-by":"publisher","first-page":"254","DOI":"10.5604\/12321966.1233568","volume":"24","author":"K Kr\u00f3l-Turmi\u0144ska","year":"2017","unstructured":"Kr\u00f3l-Turmi\u0144ska K, Olender A (2017) Human infections caused by free-living amoebae. Ann Agric Environ Med 24:254\u2013260. https:\/\/doi.org\/10.5604\/12321966.1233568","journal-title":"Ann Agric Environ Med"},{"key":"7953_CR24","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.riam.2009.06.003","volume":"26","author":"R Laniado-Labor\u00edn","year":"2009","unstructured":"Laniado-Labor\u00edn R, Cabrales-Vargas MN (2009) Amphotericin B: side effects and toxicity. Rev Iberoam Micol 26:223\u2013227. https:\/\/doi.org\/10.1016\/j.riam.2009.06.003","journal-title":"Rev Iberoam Micol"},{"key":"7953_CR25","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.pt.2019.10.008","volume":"36","author":"SK Maciver","year":"2020","unstructured":"Maciver SK, Pi\u00f1ero JE, Lorenzo-Morales J (2020) Is Naegleria fowleri an emerging parasite? Trends Parasitol 36:19\u201328. https:\/\/doi.org\/10.1016\/j.pt.2019.10.008","journal-title":"Trends Parasitol"},{"key":"7953_CR26","first-page":"271","volume":"60","author":"AJ Martinez","year":"1993","unstructured":"Martinez AJ (1993) Free-living amebas: infection of the central nervous system. Mt Sinai J Med N Y 60:271\u2013278","journal-title":"Mt Sinai J Med N Y"},{"key":"7953_CR27","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1111\/j.1750-3639.1997.tb01076.x","volume":"7","author":"AJ Martinez","year":"1997","unstructured":"Martinez AJ, Visvesvara GS (1997) Free-living, amphizoic and opportunistic amebas. Brain Pathol 7:583\u2013598. https:\/\/doi.org\/10.1111\/j.1750-3639.1997.tb01076.x","journal-title":"Brain Pathol"},{"key":"7953_CR28","doi-asserted-by":"publisher","first-page":"e02410","DOI":"10.1128\/AAC.02410-18","volume":"63","author":"JE Milanes","year":"2019","unstructured":"Milanes JE, Suryadi J, Abendroth J et al (2019) Enzymatic and structural characterization of the Naegleria fowleri glucokinase. Antimicrob Agents Chemother 63:e02410\u2013e02418. https:\/\/doi.org\/10.1128\/AAC.02410-18","journal-title":"Antimicrob Agents Chemother"},{"key":"7953_CR29","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1080\/20477724.2021.1985892","volume":"116","author":"MR Mungroo","year":"2022","unstructured":"Mungroo MR, Khan NA, Maciver S, Siddiqui R (2022) Opportunistic free-living amoebal pathogens. Pathog Glob Health 116:70\u201384. https:\/\/doi.org\/10.1080\/20477724.2021.1985892","journal-title":"Pathog Glob Health"},{"key":"7953_CR30","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1111\/j.1365-3024.2005.00799.x","volume":"27","author":"Y-H Oh","year":"2005","unstructured":"Oh Y-H, Jeong S-R, Kim J-H et al (2005) Cytopathic changes and pro-inflammatory cytokines induced by Naegleria fowleri trophozoites in rat microglial cells and protective effects of an anti-Nfa1 antibody. Parasite Immunol 27:453\u2013459. https:\/\/doi.org\/10.1111\/j.1365-3024.2005.00799.x","journal-title":"Parasite Immunol"},{"key":"7953_CR31","doi-asserted-by":"publisher","first-page":"1989","DOI":"10.1128\/JCM.02300-16","volume":"55","author":"TYY Ong","year":"2017","unstructured":"Ong TYY, Khan NA, Siddiqui R (2017) Brain-eating amoebae: predilection sites in the brain and disease outcome. J Clin Microbiol 55:1989\u20131997. https:\/\/doi.org\/10.1128\/JCM.02300-16","journal-title":"J Clin Microbiol"},{"key":"7953_CR32","doi-asserted-by":"publisher","first-page":"T233","DOI":"10.1530\/JME-18-0045","volume":"61","author":"BVL Potter","year":"2018","unstructured":"Potter BVL (2018) Sulfation pathways: steroid sulphatase inhibition via aryl sulphamates: clinical progress, mechanism and future prospects. J Mol Endocrinol 61:T233\u2013T252. https:\/\/doi.org\/10.1530\/JME-18-0045","journal-title":"J Mol Endocrinol"},{"key":"7953_CR33","doi-asserted-by":"publisher","first-page":"2626","DOI":"10.1021\/acschemneuro.7b00430","volume":"8","author":"K Rajendran","year":"2017","unstructured":"Rajendran K, Anwar A, Khan NA, Siddiqui R (2017) Brain-eating amoebae: silver nanoparticle conjugation enhanced efficacy of anti-amoebic drugs against Naegleria fowleri. ACS Chem Neurosci 8:2626\u20132630. https:\/\/doi.org\/10.1021\/acschemneuro.7b00430","journal-title":"ACS Chem Neurosci"},{"key":"7953_CR34","doi-asserted-by":"publisher","first-page":"2692","DOI":"10.1021\/acschemneuro.9b00111","volume":"10","author":"K Rajendran","year":"2019","unstructured":"Rajendran K, Anwar A, Khan NA et al (2019) trans -cinnamic acid conjugated gold nanoparticles as potent therapeutics against brain-eating amoeba Naegleria fowleri. ACS Chem Neurosci 10:2692\u20132696. https:\/\/doi.org\/10.1021\/acschemneuro.9b00111","journal-title":"ACS Chem Neurosci"},{"key":"7953_CR35","doi-asserted-by":"publisher","first-page":"789","DOI":"10.3390\/microorganisms8050789","volume":"8","author":"A Rizo-Liendo","year":"2020","unstructured":"Rizo-Liendo A, Sifaoui I, Cartuche L et al (2020) Evaluation of indolocarbazoles from Streptomyces sanyensis as a novel source of therapeutic agents against the brain-eating amoeba Naegleria fowleri. Microorganisms 8:789. https:\/\/doi.org\/10.3390\/microorganisms8050789","journal-title":"Microorganisms"},{"key":"7953_CR36","doi-asserted-by":"publisher","first-page":"e00344","DOI":"10.1128\/AAC.00344-20","volume":"64","author":"MJ Sarink","year":"2020","unstructured":"Sarink MJ, Tielens AGM, Verbon A et al (2020) Inhibition of fatty acid oxidation as a new target to treat primary amoebic meningoencephalitis. Antimicrob Agents Chemother 64:e00344\u2013e00320. https:\/\/doi.org\/10.1128\/AAC.00344-20","journal-title":"Antimicrob Agents Chemother"},{"key":"7953_CR37","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1016\/j.actatropica.2016.09.009","volume":"164","author":"R Siddiqui","year":"2016","unstructured":"Siddiqui R, Ali IKM, Cope JR, Khan NA (2016) Biology and pathogenesis of Naegleria fowleri. Acta Trop 164:375\u2013394. https:\/\/doi.org\/10.1016\/j.actatropica.2016.09.009","journal-title":"Acta Trop"},{"key":"7953_CR38","doi-asserted-by":"publisher","first-page":"561","DOI":"10.3390\/antibiotics12030561","volume":"12","author":"R Siddiqui","year":"2023","unstructured":"Siddiqui R, Rawas-Qalaji M, El-Gamal MI et al (2023) Novel anti-acanthamoebic activities of Irosustat and STX140 and their nanoformulations. Antibiotics 12:561. https:\/\/doi.org\/10.3390\/antibiotics12030561","journal-title":"Antibiotics"},{"key":"7953_CR39","doi-asserted-by":"publisher","first-page":"7634","DOI":"10.1021\/acs.jmedchem.5b00386","volume":"58","author":"MP Thomas","year":"2015","unstructured":"Thomas MP, Potter BVL (2015) Discovery and development of the aryl O -sulfamate pharmacophore for oncology and women\u2019s health. J Med Chem 58:7634\u20137658. https:\/\/doi.org\/10.1021\/acs.jmedchem.5b00386","journal-title":"J Med Chem"},{"key":"7953_CR40","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1097\/QCO.0b013e32833ed78b","volume":"23","author":"GS Visvesvara","year":"2010","unstructured":"Visvesvara GS (2010) Amebic meningoencephalitides and keratitis: challenges in diagnosis and treatment. Curr Opin Infect Dis 23:590\u2013594. https:\/\/doi.org\/10.1097\/QCO.0b013e32833ed78b","journal-title":"Curr Opin Infect Dis"},{"key":"7953_CR41","first-page":"153","volume-title":"Handbook of clinical neurology","author":"GS Visvesvara","year":"2013","unstructured":"Visvesvara GS (2013) Infections with free-living amebae. In: Handbook of clinical neurology. Elsevier, pp 153\u2013168"},{"key":"7953_CR42","doi-asserted-by":"publisher","first-page":"25s","DOI":"10.1111\/j.1550-7408.1990.tb01142.x","volume":"37","author":"GS Visvesvara","year":"1990","unstructured":"Visvesvara GS, Stehr-Green JK (1990) Epidemiology of free-living ameba infections. J Protozool 37:25s\u201333s. https:\/\/doi.org\/10.1111\/j.1550-7408.1990.tb01142.x","journal-title":"J Protozool"},{"key":"7953_CR43","doi-asserted-by":"publisher","first-page":"e1007245","DOI":"10.1371\/journal.ppat.1007245","volume":"14","author":"W Zhou","year":"2018","unstructured":"Zhou W, Debnath A, Jennings G et al (2018) Enzymatic chokepoints and synergistic drug targets in the sterol biosynthesis pathway of Naegleria fowleri. PloS Pathog 14:e1007245. https:\/\/doi.org\/10.1371\/journal.ppat.1007245","journal-title":"PloS Pathog"}],"container-title":["Parasitology Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00436-023-07953-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00436-023-07953-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00436-023-07953-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,11]],"date-time":"2023-10-11T10:21:05Z","timestamp":1697019665000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00436-023-07953-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,4]]},"references-count":43,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2023,11]]}},"alternative-id":["7953"],"URL":"https:\/\/doi.org\/10.1007\/s00436-023-07953-w","relation":{},"ISSN":["0932-0113","1432-1955"],"issn-type":[{"value":"0932-0113","type":"print"},{"value":"1432-1955","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,9,4]]},"assertion":[{"value":"22 May 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 August 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 September 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate and consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}